The gut-pancreas axis in type 1 diabetes a focus on environmental factors 2023 Laboratoř buněčné a molekulární imunologieFloyel T.Funda D.Dodero V.Haupt-Jorgensen M.Frontiers in Endocrinology. 2023; 14); 127029710.3389/fendo.2023.1270297
Protective Effect of Vegan Microbiota on Liver Steatosis Is Conveyed by Dietary Fiber: Implications for Fecal Microbiota Transfer Therapy 2023 Laboratoř gnotobiologieĎásková N.Heczková M.Modos I.Hradecký J.Hudcovic T.Kuzma M.Pelantová H.Bušková I.Sticová E.Funda D.Goliáš J.Draboňová B.Jarkovská J.Králová M.Cibulková I.Gojda J.Cahová M.Nutrients. 2023; 15(2); 45410.3390/nu15020454
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection 2022 Laboratoř buněčné a molekulární imunologieVanDyke D.Iglesias M.Tomala J.Young A.Smith J.Perry J.Gebara E.Cross A.Cheung L.Dykema A.Orcutt-Jahns B.Henclová T.Goliáš J.Balolong J.Tomasovic L.Funda D.Meyer A.Pardoll D.Hester J.Issa F.Hunter C.Anderson M.Bluestone J.Raimondi G.Spangler J.Cell Reports. 2022; 41(3); 11147810.1016/j.celrep.2022.111478
Low-carbohydrate diet in children and young people with type 1 diabetes: A randomized controlled trial with cross-over design 2024 Laboratoř buněčné a molekulární imunologieNeuman V.Plachý L.Drnková L.Pruhová S.Koloušková S.Obermannová B.Amaratunga S.Maratová K.Kulich M.Havlík J.Funda D.Cinek O.Šumník Z.Diabetes Research and Clinical Practice. 2024; 217(November); 11184410.1016/j.diabres.2024.111844
Olfactory Evaluation in Clinical Medical Practice 2022 Laboratoř buněčné a molekulární imunologieČervený K.Janoušková K.Vaněčková K.Zavázalová S.Funda D.Astl J.Holý R.Journal of Clinical Medicine. 2022; 11(22); 662810.3390/jcm11226628
Local angiotensin-converting enzyme 2 gene expression in kidney allografts is not affected by renin-angiotensin-aldosterone inhibitors 2021 Laboratoř buněčné a molekulární imunologieCahová M.Květoň M.Petr V.Funda D.Daňková H.Viklický O.Hrubá P.Kidney & Blood Pressure Research. 2021; 46(2); 245-24910.1159/000513710
Gluten-free diet in children with recent-onset type 1 diabetes: A 12-month intervention trial 2020 Laboratoř buněčné a molekulární imunologieNeuman V.Pruhová S.Kulich M.Koloušková S.Vosáhlo J.Romanová M.Petruželková L.Obermannová B.Funda D.Cinek O.Šumník Z.Diabetes Obesity & Metabolism. 2020; 22(5); 866-87210.1111/dom.13974
Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor 2019 Laboratoř buněčné a molekulární imunologieNeuman V.Cinek O.Funda D.Hudcovic T.Goliáš J.Kramná L.Petruželková L.Pruhová S.Šumník Z.Diabetologia. 2019; 62(7); 1291-129610.1007/s00125-019-4869-2
Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models? 2019 Laboratoř buněčné a molekulární imunologieFunda D.Palová-Jelinková L.Goliáš J.Kroulíková Z.Fajstová A.Hudcovic T.Spíšek R.Frontiers in Immunology. 2019; 10(MAY 14); 96710.3389/fimmu.2019.00967
